Compare, Analyse Wockhardt with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs TEVA PHARMA (Israel) - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   TEVA PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
TEVA PHARMA
Dec-13
WOCKHARDT/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0122,967-   
Low Rs5322,577-   
Sales per share (Unadj.) Rs355.91,702.7-  
Earnings per share (Unadj.) Rs-60.3106.4-  
Cash flow per share (Unadj.) Rs-46.8244.0-  
Dividends per share (Unadj.) Rs0.0193.11-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs257.81,891.4-  
Shares outstanding (eoy) m110.63848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.21.6 133.2%   
Avg P/E ratio x-12.826.1 -49.1%  
P/CF ratio (eoy) x-16.511.4 -145.3%  
Price / Book Value ratio x3.01.5 204.2%  
Dividend payout %087.5 -0.0%   
Avg Mkt Cap Rs m85,3792,350,758 3.6%   
No. of employees `0006.344.9 13.9%   
Total wages/salary Rs m9,3710-   
Avg. sales/employee Rs Th6,295.032,126.4 19.6%   
Avg. wages/employee Rs Th1,498.30-   
Avg. net profit/employee Rs Th-1,066.32,006.9 -53.1%   
INCOME DATA
Net Sales Rs m39,3691,443,919 2.7%  
Other income Rs m1,2020-   
Total revenues Rs m40,5711,443,919 2.8%   
Gross profit Rs m18395,418 0.0%  
Depreciation Rs m1,495116,713 1.3%   
Interest Rs m2,55528,361 9.0%   
Profit before tax Rs m-2,830250,344 -1.1%   
Minority Interest Rs m01,137 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582-164,337 2.2%   
Tax Rs m257-3,056 -8.4%   
Profit after tax Rs m-6,66990,201 -7.4%  
Gross profit margin %027.4 0.2%  
Effective tax rate %-9.1-1.2 743.9%   
Net profit margin %-16.96.2 -271.1%  
BALANCE SHEET DATA
Current assets Rs m33,796975,218 3.5%   
Current liabilities Rs m26,917850,472 3.2%   
Net working cap to sales %17.58.6 202.2%  
Current ratio x1.31.1 109.5%  
Inventory Days Days7991 87.4%  
Debtors Days Days8996 93.0%  
Net fixed assets Rs m39,664471,616 8.4%   
Share capital Rs m5533,554 15.6%   
"Free" reserves Rs m27,9680-   
Net worth Rs m28,5221,603,920 1.8%   
Long term debt Rs m21,731738,308 2.9%   
Total assets Rs m81,6203,299,818 2.5%  
Interest coverage x-0.19.8 -1.1%   
Debt to equity ratio x0.80.5 165.5%  
Sales to assets ratio x0.50.4 110.2%   
Return on assets %-5.03.6 -140.3%  
Return on equity %-23.45.6 -415.7%  
Return on capital %-7.74.9 -155.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,0190-   
CASH FLOW
From Operations Rs m684230,086 0.3%  
From Investments Rs m6,302-81,529 -7.7%  
From Financial Activity Rs m-7,695-276,004 2.8%  
Net Cashflow Rs m-664-127,446 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare WOCKHARDT With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare WOCKHARDT With: JUBILANT LIFE SCIENCES  PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  GSK PHARMA  ORCHID PHARMA LTD  



Today's Market

Indian Indices Trade on a Volatile Note; Healthcare and Banking Stocks Witness Buying(12:30 pm)

Share markets in India are presently trading marginally higher. Sectoral indices are trading mixed with stocks in the metal sector and IT sector.

Related Views On News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Oct 22, 2019 03:05 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS